Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 18Terminated 4Unknown 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Hematologic Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Leukemia 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Voriconazole × Clear all
NCT04743544 2021-02-08

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

Dokuz Eylul University

Unknown
62 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT04547335 2020-09-16

The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole

Dokuz Eylul University

Unknown
34 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT01501708 2016-05-10

Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown
55 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡